Bryostatin 1 (bryo1)-induced monocytic differentiation in THP-1 human leukemia cells is associated with enhanced c-fyn tyrosine kinase and M-CSF receptors

Leukemia Research

Volumn 21, Issue 5, 1997, Pages 391-397

  Li, Yan ^a,b   Mohammad, Ramzi M ^a   Al Katib, Ayad ^a   Varterasian, Mary L ^a   Chen, Ben ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Bryostatin; Differentiation; fyn kinase; M CSF receptor; PKC

Indexed keywords

BRYOSTATIN 1; COLONY STIMULATING FACTOR 1; GROWTH FACTOR RECEPTOR; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; PROTEIN TYROSINE KINASE;

ANTIGEN EXPRESSION; ARTICLE; AUTOPHOSPHORYLATION; CELL ADHESION; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LEUKEMIA CELL; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL DIVISION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KINETICS; LACTONES; LEUKEMIA, MONOCYTIC, ACUTE; MACROLIDES; MACROPHAGES; MONOCYTES; PROTEIN KINASE C; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-FYN; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0030807575     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(96)00078-1     Document Type: Article

References (32)

1. Pettit G. R. (1991) The Bryostatins (Herz W., Kirby G. W., Steglich W. & Tamm C. H., Eds), pp. 153-195. Progress in the chemistry of organic natural products. Springer, Vienna.
2. Petti G. R., Herald S. L., Doubek D. L., Herald D. L., Arnold E. & Clardy J. (1982) Isolation and structure of bryostatin 1. J. Am. Chem. Soc. 104, 6846.
3. Hornung R. L., Pearson J. W., Beckwith M. & Longo D. L. (1992) Preclinical evaluation of bryostatin as an anticancer agent against several murine tumor cell lines: in vitro versus in vivo activity. Cancer Res. 52, 101.
4. Jones R. J., Sharkis S. J., Miller C. B., Rowinsky E. K., Burke P. J. & May W. S. (1990) Bryostatin 1, a unique biological response modifier: antileukemia activity in vitro. Blood 75, 1319.
5. Lilly M., Brown C., Pettit G. R. & Kraft A. (1991) Bryostatin 1: a potential anti-leukemic agent for chronic myelomonocytic leukemia. Leukemia 5, 283.
6. Al-Katib A., Mohammad R., Khan K., Dan M., Pettit G. R. & Sensenbrenner L. (1993) Bryostatin 1-induced modulation of the acute lymphoblastic leukemia cell line Reh. J. Immunother. 14, 33.
7. Drexler H. G., Gignac S. M., Jones R. A., Scott C. S., Pettit G. R. & Hoffbrand A. V. (1989) Bryostatin 1 induces differentiation of B-chronic lymphocytic leukemia cells. Blood 74, 1747.
8. van der Hem K. G., Drager A. M., Huijgens P. C., Tol C., Deville W. & Langenhuijsen M. M. (1994) The differentiation inducing effect of bryostatin 5 on human myeloid blast cells is potentiated by vitamin D3. Leukemia 8, 266.
9. Al-Katib A., Mohammad R. M., Mohamed A. N., Pettit G. R. & Sensenbrenner L. L. (1990) Conversion of a high lymphoma tumor cell line to intermediate grade with TPA and bryostatin as determined by polypeptide analysis on 2D-gel electrophoresis. Hematol. Oncol. 8, 81.
10. Hess A. D., Silanskis M. K., Esa A. H., Pettit G. R. & May W. S. (1988) Activation of human T lymphocytes by bryostatin. J. Immunol. 141, 3263.
11. Tuttle T. M., Inge T. H., Bethke K. P., McCrady C. W., Pettit G. R. & Bear H. D. (1992) Activation and growth of murine tumor-specific T-cells which have in vivo activity with bryostatin 1. Cancer Res. 52, 548.
12. Sharkis S. J., Jones R. J., Bellis M. L., Demetri G. D., Griffin J. D., Civin C. & May W. S. (1990) The action of bryostatin on normal human hematopoietic progenitor is mediated by accessory cell release of growth factors. Blood 76, 716.
13. Li F., Grant S., Pettit G. R. & McCrady C. W. (1992) Bryostatin 1 modulates the proliferation and lineage commitment of human myeloid progenitor cells exposed to recombinant interleukin-3 and recombinant granulocyte-macrophage colony-stimulating factor. Blood 80, 2495.
14. Stone R. M., Sariban E., Pettit G. R. & Kufe D. W. (1988) Bryostatin 1 activates protein kinase C and induces monocytic differentiation of HL-60 cells. Blood 72, 208.
15. Kraft A. S., Smith J. B. & Berkow R. L. (1986) Bryostatin, an activator of calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic HL-60 cells. Proc. natn. Acad. Sci. U.S.A. 83, 1334.
16. Ramsdell J. S., Pettit G. R. & Tashjian A. H. Jr (1986) Three activators of protein kinase C, bryostatins, dioleins, and phorbol esters, showing differing specificities of action on GH pituitary cells. J. Biol. Chem. 261, 17073.
17. Mohammad R., Al-Katib A., Pettit G. R. & Sensenbrenner L. (1994) Successful treatment of human Waldenstrom's macroglobulinemia with combination biological and chemotherapy agents. Cancer Res. 54, 165.
18. Tsuchiya S., Kobayashi Y., Goto Y., Okumura H., Nakae S., Konno T. & Tada K. (1982) Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res. 42, 1530.
19. Barendsen N., Muller M. & Chen B. D.-M. (1990) Inhibition of TPA-induced monocytic differentiation in THP-1 human monocytic leukemic cells by staurosporine, a potent protein kinase C inhibitor. Leukemia Res. 14, 467.
20. Sherman M. L., Stone R. M., Datta R., Bernstein S. H. & Kufe D. W. (1990) Transcriptional and post-transcriptional regulation of c-jun expression during monocytic differentiation of human myeloid leukemic cells. J. Biol. Chem. 265, 3320.
21. Li Y. & Chen B. D.-M. (1995) Differential regulation of fyn-associated protein tyrosine kinase activity by macrophage colony-stimulating factor (M-CSF) and granulocyte-macrophage CSF (GM-CSF). J. Leuk. Biol. 57, 484.
22. House C. & Kemp B. E. (1987) Protein Kinase C contains a pseudosubstrate prototope in its regulatory domain. Science 238, 1726.
23. lyn) and the β-subunit of the granulocyte-macrophage colony-stimulating factor (GM-CSF) receptors in a GM-CSF-dependent human megakaryocytic leukemia cell line (M-07E). J. Immunol. 154, 2165.
24. Katagiri K., Katagiri T., Kajiyama K., Yamamoto T. & Yoshida T. (1993) Tyrosine phosphorylation of tubulin during monocytic differentiation of HL-60 cells. J. Immunol. 150, 585.
25. Sherr C. J., Rettenmier C. W., Sacca R., Roussel M. F., Look A. T. & Stanley E. R. (1985) The c-fms protooncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 41, 665.
26. Bartelmez S. H., Sacca R. & Stanley E. R. (1985) Lineage specific receptors used to identify a growth factor for developmentally early hemopoietic cells: assay for hemopoietin-2. J. Cell. Physiol. 122, 362.
27. Courtneidge S. A., Dhand R., Pilat D., Twamley G. M. & Waterfield M. D. (1993) Activation of src family kinases by colony-stimulating factor-1, and their association with its receptor. EMBO J. 12, 943.
28. Kennedy M. J., Prestigiacomo L. J., Tyler G., May W. S. & Davidson N. E. (1992) Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines. Cancer Res. 52, 1278.
29. Homma Y., Henning-Chubb C. B. & Huberman E. (1986) Translocation of protein kinase C in human leukemia cells susceptible or resistant to differentiation induced by phorbol 12-myristate 13-acetate. Proc. natn. Acad. Sci. U.S.A. 83, 7316.
30. Warrel R. M., Frankel S. R., Miller W. H., Scheinberg D. A., Itri L. M., Hittelman W. N., Vyas R., Andreef M., Tafuri A., Jakubowski A., Gabrlove J., Gordon M. S. & Dimitrovsky E. (1991) Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N. Engl. J. Med. 324, 1385.
31. Chomienne C., Ballerini P., Balitrand N., Daniel M. T., Fenaux P., Castaigne S. & Degos L. (1990) All trans retinoic acid in acute promyelocytic leukemia II. In vitro studies: structure/function relationship. Blood 76, 1710.
32. Jayson G. C., Crowther D., Prendiville J., McGown A. T., Scheid C., Stern P., Young R., Brenchley P., Chang J., Owens S. & Pettit G. R. (1995) A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusion. Br. J Cancer 72, 461.